Earlier today, a US appeals court rejected Apple’s request to pause the Apple Watch Series 9 and Ultra 2 ban as the company appeals an ITC ruling that the Apple Watch blood oxygen sensor infringes on two patents held by medical device company Masimo.
Under this decision, Apple will be barred from selling the Apple Watch Series 9 and Ultra 2 with pulse oximetry features starting tomorrow, January 18 at 5 p.m. ET.
Apple, however, has a plan. The company tells 9to5Mac that it will begin selling the Apple Watch Series 9 and Ultra 2 in the United States without the blood oxygen feature tomorrow.
more…
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
